Abstract
CD31hiEmcnhi vessels were a subtype of vessels in the murine skeletal system, with high levels of platelet and endothelial cell adhesion molecule-1 (PECAM-1/CD31) and endomucin (Emcn). They were reported coupling angiogenesis and osteogenesis during bone development. We investigated the distribution of these vessels in rat tibiae and their temporal and spatial distribution during the bone defect repair process to improve our understanding of the importance of these vessels. We confirmed that CD31hiEmcnhi vessels were specially distributed around the trabecular bones near metaphysis and endosteum in rat tibiae. At 3 days post bone injury, CD31hiEmcnhi vessels proliferated and were extensively distributed across the entire repair area. At 7 and 14 days post-injury, these vessels decreased but were specially distributed around the growing trabecular bones near the frontier growth area, suggesting that these vessels support new bone formation. The distribution of CD31hiEmcnhi vessels and the transcriptions of Hif-1α and VEGFA, as well as BMP2 and Osterix decreased at 7 and 14 days post-injury under osteoporotic conditions, in combination with insufficient osteogenesis. Our research is of great significance to help understand the important role of CD31hiEmcnhi vessels in supporting new trabecular bones formation during bone defect repair process.
Similar content being viewed by others
Introduction
The repair of injured bone involves a series of complex physiological and pathological processes. Four typical events occur during bone injury repair process: hematoma formation, organization of hematoma, primary trabecular bone formation and bone reshaping and remodeling1,2,3. New blood vessels formation, or angiogenesis, is an important event in the hematoma organization process, and some studies have suggested that angiogenesis occurs prior to the onset of osteogenesis4, 5. These new vessels supply the regenerating tissue, which has a high metabolic rate, with nutrients, remove waste products, and provide growth factors, cytokines and chemokines6. They also provide access routes for the surrounding and circulating repair cells, such as fibroblasts, stem cells, osteoprogenitors and endothelial cells, which migrate into the injured site7,8,9. Thus, angiogenesis provides the callus with nutrients, repair cells, growth factors, and an appropriate growth microenvironment for bone defect repair10.
Previous researchers have suggested a close link between angiogenesis and osteogenesis based on their close spatial and temporal association5, 9, 11, 12. Signal transmission or crosstalk between vascular endothelial cells and osteoprogenitor cells has also been demonstrated9, 13. This association is called “angiogenic-osteogenic coupling”9. In the murine skeletal system, Kusumbe et al.14 recently reported a special capillary subtype, CD31hiEmcnhi, which exhibited distinct morphological, molecular and functional properties. These special capillaries subtype were primarily distributed within the metaphysis and endosteum area, where cells maintain their growth and proliferation abilities and sustain bone development. Notably, these researchers also found that the number of CD31hiEmcnhi vessels and their surrounding osteoprogenitors were greatly reduced with age, especially in elderly mice. Their further research15 revealed that the endothelial Notch signaling, noggin and vascular endothelial growth factor (VEGF) coupled angiogenesis and osteogenesis during bone development. Hui Xie et al.16 demonstrated that the abundance of CD31hiEmcnhi vessels decreased significantly in ovariectomized (OVX) mice and that the secretion of platelet-derived growth factor-BB (PDGF-BB) by preosteoclasts induced CD31hiEmcnhi vessels growth during bone modeling and remodeling.
The promotion of osteogenesis by CD31hiEmcnhi vessels is important during the process of bone development in mice. However, the distribution of CD31hiEmcnhi vessels in the adult rat skeletal system is not clear, and the distribution and role of CD31hiEmcnhi vessels during the bone defect repair process under normal and osteoporotic conditions remain unknown. Our research focused on the close spatial and temporal associations between new vessels and migrating osteoprogenitors during the repair process, and investigated the differences in the proliferation and distribution of CD31hiEmcnhi vessels during the bone defect repair process under normal and osteoporotic conditions. We confirmed that there were CD31hiEmcnhi vessels distributing around the trabecular bones near the metaphysis and endosteum in rat tibiae. The proliferation and distribution of CD31hiEmcnhi vessels exhibited temporal-spatial specificity during the process of bone defect repair, suggesting that these vessels support new bone formation. We also compared the differences in the transcriptional levels of angiogenesis- and osteogenesis-related factors between normal and osteoporotic rats during the process of bone defect repair. We found that the defective CD31hiEmcnhi vessels formation and low transcriptional levels of hypoxia-inducible factor 1α (Hif-1α), VEGFA, bone morphogenetic protein-2 (BMP2) and Osterix after bone defect were closely related to the delayed osteogenesis under osteoporotic conditions.
Results
The repair process of the tibia drilling bone defect model involved typically intramembranous ossification
A series of physiological reactions were triggered immediately after bone injury to limit damage and restore the bone. Hematoxylin and eosin (H/E) staining revealed a highly organized granulation tissue that contained abundant cells at 3 days post-injury (Fig. 1B1). Diverse cells, such as fibroblasts, inflammatory cells, endothelial cells and osteoprogenitors, were distributed throughout the injured area (Fig. 1B2). Proliferating and migrating cells could be identified at the edge of the bone defect, which were more likely derived from the nearby endosteum (Fig. 1B3). Plenty of trabecular bones had been formed inside the injured region at 7 days post-injury. The trabecular bones near the frontier growth area exhibited smaller volume and thickness, while the trabecular bones away from the frontier growth area exhibited larger volume and thickness (Fig. 1C1). The overall shape of new trabecular bones was consistent with the migration of proliferating endosteal cells. Blue-stained osteoblasts adhered on the surface of trabecular bones. Osteoblasts secreted osteoid and embedded themselves in the bone lacunae. Vascular structures were distributed both at the surface and among the trabecular bones. Osteoid structures could be observed at the front of the frontier growth area, confirming the formation of new bones (Fig. 1C3). More trabecular bones were formed and connected the bilateral cortical bones at 14 days post-injury. The volume and thickness of the trabecular bones at the center region became small, indicating that the bones were undergoing resorption and that the repair process was in the bone remodeling and reshaping stage. The marrow cavity began to link together at this time point (Fig. 1D1). H/E staining revealed no chondrocyte formation inside the injured hole during the repair process.
The drilling site of the tibia bone defect and the repair process at different time points. (A) X-ray of the tibia bone defect showing the drilling site. The white arrow was pointed to the tibial crest. The diameter of the hole is 2 mm. (B–D) H/E staining of the injured region at 3, 7 and 14 days post-injury. DPI: days post-injury. (B). The hematoma has been well organized at 3 days post-injury, with plenty of vascular tissues invading into and a large number of cells migrating into the inner. (C) As the dotted line showed, the frontier growth area could be identified at 7 days post-injury. The thickness of trabecular bones near the frontier growth area was relatively small compared with those away from the frontier growth area. Osteoblasts could be found at the surface of trabecular bones. Vascular structures existed both at the surface and periphery of trabecular bones. A large number of cells accumulated at the forward of frontier growth area and new trabecular bones was forming. (D) Newly formed trabecular bones have bridged the bilateral cortical bones at 14 days post-injury. At this time point, the repair period was in the process of bone remodeling stage. Bone marrow cavity has been gradually recanalized.
Osterix + Emcn+ cells mediated new bone formation
Emcn antibody was used to label capillaries, and osterix antibody was used to label osteoprogenitors and osteoblasts. Emcn/osterix double fluorescent labeling revealed how new vessels grew and osteoprogenitors migrated into the center of the injured zone and showed their distribution and location relationship. At 3 days post-injury, Emcn+ capillaries were widely distributed in the injured zone (Fig. 2A). Capillaries at the center of the injured zone were fewer in number and were more porous than those at the lateral (Fig. 2B). Capillary sprouting could be observed near the center of the injured zone, indicating angiogenesis was happening (Fig. 2C). Osterix+ cells were primarily distributed in the endosteal region near the damaged cortical bones, while only a few scattered cells were distributed at the center of the injured zone. The osterix+ cells were most likely derived from endosteum and bone marrow (Fig. 2B). Emcn+ capillaries were distributed extensively in the injured zone at 7 days post-injury and were more orderly than those observed at 3 days post-injury (Fig. 2D,E). Emcn+ capillaries were distributed both at the surface and the periphery of trabecular bones (Fig. 2E). The capillaries at the periphery of trabecular bones branched at the end and connected with the capillaries at the surface of trabecular bones (Fig. 2F). As expected, a large number of osterix+ cells were present around the newly formed trabecular bones, indicating that the trabecular bones were formed by osterix+ cells secreting osteoid. Some osterix+ cells were present attaching on the capillaries (Fig. 2E,F). Notably, some osterix+ Emcn+ cells were distributed at the edge of newly formed trabecular bones and likely mediated new bone formation (Fig. 2C,F). Emcn protein was identified as an endothelial sialomucin expressed on the surface of endothelial cells. The co-localization of osterix and Emcn may indicate the endothelial characteristics of osteoblasts, or as microcapillary pericytes, which were directly connected with their supporting capillaries. The exchange of nutrients, oxygen, metabolic products and endocrine factors occurred between capillaries and osterix+ Emcn+ cells.
The invasion of Emcn+ capillaries and the proliferation and migration of osterix+ cells during the repair process. (A–C) The distribution of Emcn+ vessels and osterix+ cells at 3 days post-injury. (A) Emcn+ vessels were extensively distributed in the injured area, exhibiting a denser distribution in the lateral area and looser distribution in the inner area. (B) Proliferating and migrating osterix+ cells were primarily distributed at the lateral side of the repairing region, and displayed a migrating tendency to the inner. (C) The sprouting of Emcn+ capillaries could be observed inside the repair area (white thin-tailed arrow). Some osterix+ cells were tightly connected with Emcn+ capillaries (white thick-tailed arrow). (D–F) The distribution of Emcn+ capillaries and osterix+ cells at 7 days post-injury. (D) Emcn+ capillaries were distributed in a more orderly manner, and were observed both at the surface and the periphery of newly formed trabecular bones. Near the frontier growth area distributed a large number of osterix+ cells. (E) Most osterix+ cells were distributed on the surface of newly formed trabecular bones. (F) Branches of Emcn+ vessels among the new trabecular bones could be observed (white thin-tailed arrow). Osterix+ Emcn+ cells were identified and were distributed at the surface of new trabecular bones (white thick-tailed arrow).
CD31hiEmcnhi vessels were distributed especially in areas with high levels of metabolic and osteogenic activity
The distribution of CD31hiEmcnhi vessels in rat bone exhibited spatial specificity. These vessels were highly distributed in areas with high levels of metabolic and osteogenic activity. High levels of CD31hiEmcnhi vessels were distributed at the surface of the growing trabecular bones near metaphysis and endosteum in the rat tibiae (Fig. 3A,B), while only a few CD31hiEmcnhi vessels were distributed at the surface of the trabecular bones inside the bone marrow cavity (Fig. 3C). These appearances were similar with what described in the previous report. Capillaries were observed both at the surface and the periphery of trabecular bones at 7 days post-injury. Notably, the trabecular bones near the frontier growth area were surrounded by high levels of CD31hiEmcnhi vessels (Fig. 3D,E), while relatively few CD31hiEmcnhi vessels were observed at the surface of the trabecular bones away from the frontier growth area (Fig. 3D,F). It was the fact that bones near the frontier growth area were undergoing bone formation, which had a high metabolic and osteogenic activity. While bones away from the frontier growth area were more likely undergoing bone resorption and remodeling (Fig. 3D). The high distribution of CD31hiEmcnhi vessels at the surface of the growing new trabecular bones suggested that CD31hiEmcnhi vessels could support new bone formation.
The distribution of CD31hiEmcnhi vessels had spatial specificity both in normal rat tibiae and the injured tibiae during repair process. (A–C) The distribution of CD31hiEmcnhi vessels in different parts of normal rat tibiae. (A) Metaphysis. (B) Diaphysis. (C) Bone marrow cavity. Plenty of CD31hiEmcnhi vessels were distributed around the growing trabecular bones near metaphysis and endosteum areas (white thin-tailed arrow). While at the surface of trabecular bones inside the bone cavity distributed only a few CD31hiEmcnhi vessels (white thick-tailed arrow). (D–F) CD31hiEmcnhi vessels distributed differently at different portion of the repair area at 7 days post-injury. (D) The overall appearance of CD31/Emcn double-immunofluorescence staining at 7 days post-injury showed the distribution of CD31hiEmcnhi vessels. (E) High levels of CD31hiEmcnhi vessels were distributed at the surface of the growing trabecular bones near the frontier growth area. (F) While at the surface of trabecular bones away from the frontier growth area exhibited a low level distribution of CD31hiEmcnhi vessels.
CD31hiEmcnhi vessels proliferated in the bone defect repair process supporting new trabecular bones formation
The distribution of CD31hiEmcnhi vessels exhibited temporal-spatial specificity during the bone defect repair process. At 3 days post-injury, the regenerating vessels have invaded into the injured region. The proportion of CD31hiEmcnhi vessels was very high (Fig. 4A). Well-organized tissues have replaced the hematoma at this time point. Abundant new vessels and proliferating and migrating osterix+ osteoprogenitors or osteoblasts were distributed across the repair region (Fig. 4A). At 7 days post-injury, the number of CD31hiEmcnhi vessels decreased, but were specially distributed at the surface of the growing trabecular bones near the frontier growth area (Fig. 4B). Relatively few CD31hiEmcnhi vessels could be observed at the surface of the trabecular bones away from the frontier growth area. Osterix+ cells were not only distributed at the surface of trabecular bones, but were also attached on the vascular structure. At 14 days post-injury, the number of CD31hiEmcnhi vessels further decreased. Only at the surface of the trabecular bones near the lateral margin of cortical bone distributed high levels of CD31hiEmcnhi vessels. While at the surface of the trabecular bones inside the bone marrow cavity distributed few CD31hiEmcnhi vessels (Fig. 4C). Although the number of CD31hiEmcnhi vessels gradually decreased during the repair process, the vessels were specially distributed at the surface of the growing trabecular bones. These results indicated that CD31hiEmcnhi vessels support new trabecular bones formation during the bone defect repair process. Proliferating and migrating osterix+ osteoprogenitors or osteoblasts were primarily derived from the endosteum near the defect edge at 3 days post-injury (Fig. 4A). There were plenty of osterix+ cells distributed inside the vascular structure of bone marrow cavity, indicating the high proliferation of osterix+ cells at 14 days post-injury (Fig. 4C). The area of osterix+ cells significantly increased during the repair process (Fig. 4F).
The proliferation and distribution of CD31hiEmcnhi vessels and osterix+ cells at different time points during the bone defect repair process in normal rats. (A) High levels of CD31hiEmcnhi vessels were distributed across the whole repair area at 3 days post-injury. A large number of osterix+ cells were concentrated near endosteum at the damaged edge. (B) Vessels could be identified both at the surface and the periphery of trabecular bones at 7 days post-injury. Relatively high levels of CD31hiEmcnhi vessels were distributed at the surface of the growing trabecular bones near the frontier growth area. Most osterix+ cells were distributed at the surface of trabecular bones and some were attached on vessels. (C) High levels of CD31hiEmcnhi vessels were distributed at the surface of the growing trabecular bones near the lateral margin of cortical bone at 14 days post-injury. While at the surface of trabecular bones inside the cavity distributed very low level of CD31hiEmcnhi vessels. (D–F) Statistical comparisons of CD31 + Emcn+ endothelial area, CD31hiEmcnhi endothelial area and osterix+ area at 3, 7 and 14 days post-injury. *P < 0.05, n = 4.
The decreased bone mass in the process of bone defect repair under osteoporotic conditions was related with the reduction of CD31hiEmcnhi vessels and low transcriptional levels of Hif-1α, VEGFA, BMP2 and osterix
Micro-computed tomography (CT) analyses revealed that the bone volume fraction (bone volume/total volume, BV/TV), trabecular thickness (Tb.Th.) and trabecular number (Tb.N.) decreased significantly at 7 and 14 days post-injury in OVX rats, whereas the bone surface-to-volume ratio (bone surface/total volume, BS/TV) and trabecular spacing (Tb.Sp.) significantly increased (Fig. 5A–I). These changes demonstrated that the osteogenesis after bone defect in OVX rats was significantly insufficient relative to that in normal rats. H/E staining revealed that the degree of hematoma organization was significantly reduced at 3 days post-injury under osteoporotic conditions. A large number of proliferating cells accumulated at the edge of the defect. While only a small number of cells migrated into the inner portion of the repairing tissue. These results may be attributed to the lack of neovascularization (Fig. 5J). The number and thickness of newly formed trabecular bones decreased in OVX rats at 7 days post-injury, consistent with the results of micro-CT scanning. The trabecular structure was disordered compared with that in normal rats (Fig. 5K). Similarly, the number and thickness of trabecular bones at 14 days post-injury in OVX rats reduced significantly, while the space increased significantly. The entire trabecular structure was loose and porous in OVX rats compared with that in normal rats (Fig. 5L). Immunofluorescent staining revealed that the area of CD31hiEmcnhi vessels was decreased at each period of the repair process under osteoporotic conditions (Fig. 6A,C,E). The high distribution of CD31hiEmcnhi vessels at the surface of the trabecular bones near the frontier growth area was not obvious under osteoporotic conditions (Fig. 5N,O). In OVX rats, the number of osterix+ osteoprogenitors or osteoblasts decreased significantly at 3 days post-injury, and this decrease was accompanied by insufficiently invading of new blood vessels (Fig. 6B). Additionally, only a small number of osterix+ cells migrated into the center of the repairing tissue (Fig. 5M). The volume of vascular tissues at the surface and the periphery of trabecular bones was decreased in OVX rats at 7 days post-injury (Fig. 5N). In OVX rats, the high distribution of CD31hiEmcnhi vessels at the surface of the trabecular bones near the lateral margin of cortical bone was not obvious at 14 days post-injury (Fig. 5O). Obvious nonspecific staining of bone marrow was excluded when calculating the fluorescence intensity.
The repair process of the tibia drilling bone defect model in OVX rats. (A–D) Three-dimensional reconstruction after micro-CT scanning showed that new bones formations during the repair process at 7 and 14 days post-injury in OVX rats were lower than those in normal rats. (E–I) Statistical comparisons of BV/TV, Tb.Th., Tb.Sp., BS/TV and Tb.N. between normal rats and OVX rats at 7 and 14 days post-injury. *P < 0.05, n = 4. (J–L) H/E staining at different time points in the repair process of tibia drilling bone defect in OVX rats. The degree of hematoma organization at 3 days post-injury in OVX rats was obviously inadequate compared with that in normal rats (Fig. 1). The thickness of new trabecular bones was reduced at 7 days post-injury in OVX rats. The number and thickness of trabecular bones reduced, but the space increased at 14 days post-injury in OVX rats. (M–O) The proliferation and distribution of CD31hiEmcnhi vessels and osterix+ cells at different time points during the bone defect repair process in OVX rats. Compared with the repair process in normal rats, the area of CD31hiEmcnhi vessels was decreased at every time points in OVX rats. The high distribution of CD31hiEmcnhi vessels at the surface of trabecular bones near the frontier growth area at 7 days post-injury was not obvious. There was no high distribution of CD31hiEmcnhi vessels at the surface of the trabecular bones near the lateral margin of cortical bone at 14 days post-injury. The areas of osterix-staining positive at the repair region were decreased at 3, 7 and 14 days post-injury in OVX rats compared with those in normal rats.
(A–F) Statistical comparisons of CD31hiEmcnhi vessels and the area of osterix-staining positive between normal and OVX rats during the repair process. Under osteoporotic conditions, the amounts of CD31hiEmcnhi vessels and osterix+ cells were significantly reduced at 3, 7 and 14 days post-injury. (G–J) Statistical comparisons of the transcriptional levels of Hif-1α, VEGFA, BMP2 and Osterix. The transcriptions of Hif-1α and VEGFA at 3 days post-injury in OVX rats were significantly higher than those in normal rats. *P < 0.05; **P < 0.01; ***P < 0.001, n = 4.
We detected the differences in the transcriptional levels of the angiogenesis-related factors Hif-1α and VEGFA, as well as the osteogenesis-related factors BMP2 and Osterix during the repair process, to interpret the low level of angiogenesis and osteogenesis in OVX rats at the mRNA transcriptional level. Surprisingly, we found that, compared with those in normal rats, the transcriptions of Hif-1α and VEGFA in OVX rats were not decreased at 3 days post-injury, but were increased significantly (P < 0.05) (Fig. 6G,H). However, the transcriptional levels of Hif-1α and VEGFA at 7 and 14 days post-injury in OVX rats were decreased significantly compared with those in normal rats (P < 0.05) (Fig. 6G,H). The transcriptional levels of the osteogenesis-related factors BMP2 and Osterix were consistent at each time point after bone defect. Under osteoporotic conditions, the transcriptional levels of BMP2 and Osterix were significantly lower than those under normal conditions (Fig. 6I,J). The transcriptional levels of Hif-1α, VEGFA, BMP2 and Osterix in normal rats reached peak values at 7 days post-injury (Fig. 6G–J). These results suggested that the significant decrease in the transcriptional levels of angiogenesis- and osteogenesis- related factors at 7 and 14 days post injury possibly led to low levels of angiogenesis and osteogenesis in OVX rats.
Discussion
Our study focused on the dynamic distribution of CD31hiEmcnhi vessels during the bone defect repair process in normal adult rats and osteoporotic rats. Immunohistochemical staining at multiple time points revealed the proliferation and distribution of CD31hiEmcnhi vessels after bone injury. Combined with the research of Kusumbe et al., we showed that CD31hiEmcnhi vessels support new trabecular bones formation during the bone defect repair process in adult rats. We firstly detected the distribution of CD31hiEmcnhi vessels in normal rat tibiae and found that these vessels were highly located at the surface of trabecular bones near metaphysis and endosteum, where stem cells and progenitor cells maintain their self-renewal capacity and allow lifelong osteogenesis. This finding is similar to the previous results obtained in mice. Next, we found that the distribution of CD31hiEmcnhi vessels displayed temporal-spatial specificity during the repair process. At 3 days post-injury, when the hematoma was organized with abundant new vessels, high levels of CD31hiEmcnhi vessels were widely distributed across the injured region. Subsequently, CD31hiEmcnhi vessels decreased at 7 and 14 days post-injury but were specially distributed at the surface of the growing trabecular bones near the frontier growth area. By contrast, at the surface of the trabecular bones away from the frontier growth area distributed low levels of CD31hiEmcnhi vessels. These observations indicated that CD31hiEmcnhi vessels could support new trabecular bone formation during the repair process. As a contrast, under osteoporotic conditions, the distribution of CD31hiEmcnhi vessels was reduced at every period of the repair process. There were no obvious high levels of CD31hiEmcnhi vessels distributed at the surface of the new trabecular bones near the frontier growth area at 7 and 14 days post-injury in OVX rats. Meanwhile, the bone mass and bone quality repaired in OVX rats were decreased. Kusumbe et al.14 once detected the transcriptional levels of exocrine factors related to the proliferation and survival of osteoprogenitors in mice and found that the transcriptional levels of Pdgfa, Pdgfb, Tgfb1, Tgfb3 and Fgf1 were significantly higher in CD31hiEmcnhi endothelial cells. Selectively blocking the endothelial Notch signaling15 reduced the distribution of CD31hiEmcnhi vessels, shortened long bones of mice and induced bone loss. These findings further indicated the hypothesis that CD31hiEmcnhi vessels could support new trabecular bone formation in the repair process. Although more underlying mechanisms remained to be explored, the high proliferation and distribution of CD31hiEmcnhi vessels during the bone defect repair process may represent a highly organized and metabolized repair tissue that could influence the bone growth potential.
Our research confirmed that new vessels invasion occurred predominantly before the onset of osteogenesis after bone defect. Vessels are damaged after injury, leading to hematoma formation17 and innate immune response activation4, 18. Hypoxia, fibrin matrix19, inflammatory cells and cytokines are strong inducers of endothelial cells20,21,22,23. New vessels begin sprouting and invading into the hematoma. We found that at 3 days post-injury Emcn+ capillaries were distributed extensively throughout the repair region, while only a small number of osterix+ cells migrated into. A large number of proliferating osterix+ cells were found accumulating at the defect edge. Notably, we found that the invading osterix+ cells co-expressed the endothelial sialomucin protein-Emcn and were located at the edge of capillaries. This co-expression indicates a close connection between osteoblasts and capillaries. Similarly, Maes et al.24 reported that osterix+ osteoblast precursors moved into developing bones along with the invading vessels in pericyte-like fashion during endochondral bone development and endochondral healing of bone fractures, and that the pericyte-like osterix+ cells gave rise to the full differentiation spectrum of osteoblast lineage cells inside the growing bone, including the cuboidal osteoblasts covering the trabecular bone surfaces. Histological and transmission electron microscope (TEM) analysis revealed that the osterix+ cells were juxtaposed to endothelial cells and their processes closely enfolded the endothelial lining of the vessel, similar to pericytes. These findings are consistent with the characterization of osterix+ cells as a type of microvascular pericytes closely affiliated with capillary endothelial cells24, 25. However, whether osterix+ cells migrate into the specific locations, via extravascular migratory metastasis attaching on vessels or trans-endothelial migration similar to hematopoietic cells is not known. At 7 days post-injury, mature vessels inside the injured area had formed. The capillary tubes among trabecular bones are branched at the end and connected to osterix+ bone-forming cells8. These structures ensure that the osteoblasts could receive a continuous supply of nutrients and oxygen to perform their functions. Previous studies have shown that in addition to the cambial layer of the periosteum and mesenchymal stem cells in bone marrow, endosteal cells and circulating progenitors are important sources of osterix+ cells26,27,28. In our study, we did not trace the sources of the osterix+ cells. However, the location of the osterix+ area suggests that these cells were primarily derived from proliferating and migrating endosteal cells near the bone defect edge, of course bone mesenchymal stem cells cannot be excluded.
Osteoporosis represents an imbalance between osteoblastic bone formation and osteoclastic bone resorption resulting from long-term chronic inflammation and excessive osteoclast activity29. The ultimate results are bone volume loss, bone strength decrease and a high risk of bone fracture30, 31. Hif-1α is the most important regulator of oxygen homeostasis in mammals and controls physiological and pathological neo-angiogenesis32. Under acute hypoxia conditions, the transcription of Hif-1α and the stability of Hif-1α protein significantly increase. Binding of Hif-1α to the hypoxia response element (HRE) activates the transcriptions of target genes such as VEGF 33. VEGFA is the most important vascular endothelial growth factor, and has the strongest effect on inducing angiogenesis by binding to VEGF receptors (VEGFRs) on the surface of endothelial cells34. Researchers previously observed reduced bone vasculature and decreased Hif-1α and VEGF expression in the bones of OVX mice35,36,37. Our study detected that at 3 days post-injury the transcriptional levels of Hif-1α and VEGFA in OVX rats were significantly higher than that in normal rats. However, at 7 and 14 days post-injury the transcriptional levels of Hif-1α and VEGFA in OVX rats reduced and were significantly lower than that in normal rats. Our latter results were similar with the report of Li et al.36 in which they found decreased callus formation, reduced neovascularization and low levels of Hif-1α transcription in OVX rats at 14 and 28 days post-femoral fracture compared with normal rats. We attribute the high transcriptional levels of the angiogenesis-related factors Hif-1α and VEGFA at 3 days post-injury under osteoporotic conditions to the low oxygen tension of the repairing callus due to poor neovascularization in OVX rats. By contrast, in normal rats, the hematoma was well organized, and the callus was relatively rich in new vessels and oxygen. The reasons why high transcriptions of Hif-1α and VEGFA did not result in good angiogenesis in OVX rats require further investigation. BMPs play an important role in stimulating the differentiation of mesenchymal stem cells into osteoblasts, and BMP2 is one of the most important BMPs38. Osterix is a specific transcription factor of osteoprogenitors and osteoblasts, whose transcription is positively regulated by BMP239. The decreases in the transcriptional levels of BMP2 and Osterix were consistent with the low bone mass and reduced number of osterix+ cells at 3, 7 and 14 days post-injury in OVX rats.
In summary, our study is of great significance for understanding the importance of the proliferation, distribution and function of CD31hiEmcnhi vessels during the bone defect repair process. However, further investigation is required to obtain deeper knowledge of the mechanisms underlying the appearance of these vessels. Increasing the number and distribution of CD31hiEmcnhi vessels during the bone defect repair process using drug treatment or physical therapy could be important for the promotion of bone defect repair under osteoporosis and constitutes one direction of our further research.
Methods
Animal models
A tibia drilling bone defect model was used in this experiment. Surgeries were performed on 5-month-old adult female Sprague-Dawley (SD) rats weighing 280 to 320 g. The rats were anesthetized with intraperitoneal sodium pentobarbital (45 mg/kg), shaved, and placed in a supine position on the surgery table. The lower right limb was disinfected, and the skin above the tibia was cut along the bone edge. A drill bit (φ = 2 mm) was used to drill a hole in the ventral side of the tibia at the crest level. The hole did not penetrate the other side of the bone. The incised skin was carefully sutured, and the rat was placed on a heating pad until awake. Ampicillin (100 mg/kg) was injected intraperitoneally once daily for 3 consecutive days. The rats were randomly divided into 3 groups of 8 rats each based on the time of euthanasia: 3 days, 7 days and 14 days post-injury. Ovariectomies were performed on 2-month-old female SD rats according to the methods of Wronski40. Tibia drilling bone defect surgeries were performed on OVX rats 3 months later. The OVX rats were grouped as described above. The laboratory animal center of the Fourth Military Medical University provided all rats. The rats were maintained in specific pathogen-free (SPF)-class housing in the laboratory. The Ethical Committee of the Fourth Military Medical University approved this study. All procedures on rats were performed in the authorized animal care facility and were approved by the “Committee for the Care and Use of Laboratory Animals” of the Fourth Military Medical University. All methods were performed in accordance with the relevant guidelines and regulations of the People’s Republic of China.
Tibiae collection and decalcification
Four rats from each group at each time point were deeply anesthetized with intraperitoneal sodium pentobarbital (100 mg/kg). The chest was opened to expose the heart, and 500 ml of ice-cold 0.9% physiological saline was infused through the left ventricle and ascending aorta, followed by 500 ml of ice-cold 4% paraformaldehyde (PFA) in 0.1 M phosphate-buffered saline (PBS). The soft tissue of the right tibia was removed, and the injured portion of the tibia was collected. Decalcification was performed using 20% ethylenediaminetetraacetic acid (EDTA) at room temperature under constant shaking on a swing bed for 2 months.
Micro-CT analysis
The fixed tibiae were collected and scanned using a micro-CT system (GE eXplore Locus SP) with a voltage of 80 kV, intensity of 80 mA, integration time of 3000 ms, and layer thickness of 14 μm. Data were analyzed using IPL V5.15 software at the Department of Orthopaedics, Xijing Hospital, China.
Histochemical staining studies
Decalcified bones were immersed in a solution of 20% sucrose and 2% polyvinylpyrrolidone (PVP) for 72 h. Subsequently, the bones were embedded and frozen in optimal cutting temperature (OCT) compound, and 10-μm sections were longitudinally cut using a Leica CM1850 cryostat. The sections were collected on Superfrost+ microscope slides, and H/E staining was performed using the procedures described in the staining kit. Air-dried sections for immunofluorescent staining were washed 3 times with 0.1 M PBS for 5 min to moisten the slices and wash away any residual OTC. The sections were incubated with 0.01% Triton X-100 for 10 min and washed 3 times with 0.1 M PBS for 5 min. Then, the sections were blocked with 10% donkey serum at 37 °C in an incubator for 60 min. The serum was removed, and the sections were incubated with primary antibodies diluted in 5% donkey serum overnight at 4 °C. The following primary antibodies were used: endomucin (sc-19901, Santa Cruz, diluted 1:100), CD31 (ab64543, Abcam, diluted 1:200) and osterix (ab-22552, Abcam, diluted 1:200). The sections were washed 3 times for 5 min and stained with a secondary anti-goat (1:400, ab150133/ab150136; Abcam), anti-mouse (1:200, 34106ES60; Yesen), or anti-rabbit (1:400, ab150075/ab150076; Abcam) antibody for 1 h at 37 °C. Sections for nuclear staining were incubated with 10 mg/ml Hoechst (33342) for 5 min, washed 6 times with 0.1 M PBS for 5 min, mounted in anti-fade mounting medium (P0126, Beyotime) and coverslipped. A laser scanning confocal fluorescence microscope (FluoView™ FV1000) was used for observation and image capture. The immunofluorescence intensity was quantified using ImageJ software according to a previously described protocol14.
qRT-PCR
Four rats in each group were euthanized. The fresh injured tibias were excised, and the newly formed tissues inside the drilling hole were carefully and quickly collected. All procedures were performed at 4 °C. The total cellular RNA of the tissues was extracted using Trizol Reagent (Invitrogen) according to the manufacturer’s instructions. RNA samples from injured tibial tissues collected from normal and osteoporotic rats at different time points (3, 7 and 14 days) were examined by measuring the ratio of the optical density at 260 nm and 280 nm (OD260/280). Samples with a ratio of 2.0 were used for reverse transcription. cDNA was synthesized using 1 μg of RNA and a Revert Aid First Strand cDNA Synthesis Kit (TaKaRa, Dalian, China). qRT-PCR analyses were performed in triplicate using an SYBR Premix Ex TaqTM kit (TaKaRa, Dalian, China) and detected with Bio-Rad X97 System software. Melting curve analysis was performed for each qRT-PCR assay to minimize nonspecific reactions. Data were normalized to the transcriptional level of glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The primer sequences for the detected genes are listed in Table 1.
Statistical analysis
All data were presented as means ± standard deviations. Two-tailed Student’s t test was used to calculate the significance of differences between groups. P < 0.05 was considered statistically significant. GraphPad Prism software (Version 6.01) was used for all statistical analyses.
References
Sathyendra, V. & Darowish, M. Basic science of bone healing. Hand Clin 29, 473–481 (2013).
Schmidt-Bleek, K., Petersen, A., Dienelt, A., Schwarz, C. & Duda, G. N. Initiation and early control of tissue regeneration - bone healing as a model system for tissue regeneration. Expert Opin Biol Ther 14, 247–259 (2014).
Shapiro, F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15, 53–76 (2008).
Schmidt-Bleek, K. et al. Initial immune reaction and angiogenesis in bone healing. J Tissue Eng Regen Med 8, 120–130 (2014).
Saran, U., Gemini, P. S. & Chatterjee, S. Role of angiogenesis in bone repair. Arch biochem biophys 561, 109–117 (2014).
Kanczler, J. M. & Oreffo, R. O. Osteogenesis and angiogenesis: the potential for engineering bone. Eur Cell Mater 15, 100–114 (2008).
Maes, C. et al. Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels. Dev Cell 19, 329–344 (2010).
Sivaraj, K. K. & Adams, R. H. Blood vessel formation and function in bone. Development 143, 2706–2715 (2016).
Brandi, M. L. & Collin-Osdoby, P. Vascular biology and the skeleton. J Bone miner Res 21, 183–192 (2006).
Horner, A. et al. Immunolocalisation of vascular endothelial growth factor (VEGF) in human neonatal growth plate cartilage. J Anat 194(Pt 4), 519–524 (1999).
Dirckx, N., Van Hul, M. & Maes, C. Osteoblast recruitment to sites of bone formation in skeletal development, homeostasis, and regeneration. Birth Defects Res C Embryo Today 99, 170–191 (2013).
Maes, C. Role and regulation of vascularization processes in endochondral bones. Calcif Tissue Int 92, 307–323 (2013).
Schipani, E., Maes, C., Carmeliet, G. & Semenza, G. L. Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF. J Bone Miner Res 24, 1347–1353 (2009).
Kusumbe, A. P., Ramasamy, S. K. & Adams, R. H. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507, 323–328 (2014).
Ramasamy, S. K., Kusumbe, A. P., Wang, L. & Adams, R. H. Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature 507, 376–380 (2014).
Xie, H. et al. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat Med 20, 1270–1278 (2014).
Kolar, P. et al. The early fracture hematoma and its potential role in fracture healing. Tissue Eng Part B Rev 16, 427–434 (2010).
Schmidt-Bleek, K. et al. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res 347, 567–573 (2012).
Nathaniel, B. W. et al. Assessing angiogenic responses induced by primary human prostate stromal cells in a three-dimensional fibrin matrix assay. Oncotarget (2016).
Kigami, R. et al. FGF-2 angiogenesis in bone regeneration within critical-sized bone defects in rat calvaria. Implant Dent 22, 422–427 (2013).
Dohle, E. et al. Macrophage-mediated angiogenic activation of outgrowth endothelial cells in co-culture with primary osteoblasts. Eur Cell Mater 27, 149–164, 164–165 (2014).
Croes, M. et al. Proinflammatory T cells and IL-17 stimulate osteoblast differentiation. Bone 84, 262–270 (2016).
Karnes, J. M., Daffner, S. D. & Watkins, C. M. Multiple roles of tumor necrosis factor-alpha in fracture healing. Bone 78, 87–93 (2015).
Kalajzic, I. et al. Pericyte/myofibroblast phenotype of osteoprogenitor cell. J Musculoskelet Neuronal Interact 7, 320–322 (2007).
Maes, C. et al. Osteoblast Precursors, but Not Mature Osteoblasts, Move into Developing and Fractured Bones along with Invading Blood Vessels. Dev Cell 19, 329–344 (2010).
Matic, I. et al. Quiescent Bone Lining Cells Are a Major Source of Osteoblasts During Adulthood. Stem Cells (2016).
Shirley, D., Marsh, D., Jordan, G., McQuaid, S. & Li, G. Systemic recruitment of osteoblastic cells in fracture healing. J Orthop Res 23, 1013–1021 (2005).
Jones, E. & Yang, X. Mesenchymal stem cells and bone regeneration: current status. Injury 42, 562–568 (2011).
Labouesse, M. A. et al. Associations among endocrine, inflammatory, and bone markers, body composition and weight loss induced bone loss. Bone 64, 138–146 (2014).
den Uyl, D., van Schoor, N. M., Bravenboer, N., Lips, P. & Lems, W. F. Low grade inflammation is associated with lower velocity of sound and broadband ultrasound attenuation in older men, but not with bone loss or fracture risk in a longitudinal aging study. Bone 81, 270–276 (2015).
Pagani, S., Fini, M., Giavaresi, G., Salamanna, F. & Borsari, V. The active role of osteoporosis in the interaction between osteoblasts and bone metastases. Bone 79, 176–182 (2015).
Pugh, C. W. & Ratcliffe, P. J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9, 677–684 (2003).
Manalo, D. J. et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 105, 659–669 (2005).
Nagy, J. A., Dvorak, A. M. & Dvorak, H. F. VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2, 251–275 (2007).
Zhao, Q. et al. Mice with increased angiogenesis and osteogenesis due to conditional activation of HIF pathway in osteoblasts are protected from ovariectomy induced bone loss. Bone 50, 763–770 (2012).
Li, W., Wang, K., Liu, Z. & Ding, W. HIF-1alpha change in serum and callus during fracture healing in ovariectomized mice. Int J Clin Exp Pathol 8, 117–126 (2015).
Faienza, M. F. et al. Mechanisms of enhanced osteoclastogenesis in girls and young women with Turner’s Syndrome. Bone 81, 228–236 (2015).
Luu, H. H. et al. Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25, 665–677 (2007).
Zhu, J., Shimizu, E., Zhang, X., Partridge, N. C. & Qin, L. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J Cell Biochem 112, 1749–1760 (2011).
Wronski, T. J., Dann, L. M., Scott, K. S. & Cintron, M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45, 360–366 (1989).
Acknowledgements
The Hospital and Department of Orthopaedics Research Institute, where the authors work, supported this study. This study was also supported by the National Natural Science Foundation of China (Grant Nos 81430049, 81572192, and 81272011).
Author information
Authors and Affiliations
Contributions
J.M.W., Y.G., L.Y. and G.X.P. conceived the experiments. J.M.W., Y.G., P.Z.Ch., D.L.L., H.J.J., Ch.L.J. and S.S.Zh. created the animal bone defect models. J.M.W., Y.G., Ch.Sh. and J.Q.L. performed the micro-CT scanning experiments. J.M.W., Y.G., Y.S., T.Q.C. and Ch.M.W. conducted the histochemical staining experiments. J.M.W. and Y.G. performed the qRT-PCR assays. J.M.W., Y.G., L.Y. and G.X.P. analyzed the results. J.M.W., Y.G. and L.Y. prepared all figures and wrote the manuscript. All authors reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, J., Gao, Y., Cheng, P. et al. CD31hiEmcnhi Vessels Support New Trabecular Bone Formation at the Frontier Growth Area in the Bone Defect Repair Process. Sci Rep 7, 4990 (2017). https://doi.org/10.1038/s41598-017-04150-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-017-04150-5
- Springer Nature Limited
This article is cited by
-
The Role of Osteogenic Effect and Vascular Function in Bone Health in Hypertensive Rats: A Study of Anti-hypertensive and Hemorheologic Drugs
Calcified Tissue International (2023)
-
Osteoconductive properties of upside-down bilayer collagen membranes in rat calvarial defects
International Journal of Implant Dentistry (2021)
-
Skeleton-vasculature chain reaction: a novel insight into the mystery of homeostasis
Bone Research (2021)
-
Advances in the understanding of the role of type-H vessels in the pathogenesis of osteoporosis
Archives of Osteoporosis (2020)
-
The association between CD31hiEmcnhi endothelial cells and bone mineral density in Chinese women
Journal of Bone and Mineral Metabolism (2019)